FV

Fernando G. Vieira

AI Als Therapy Development Institute: 13 patents #1 of 14Top 8%
📍 Newton, MA: #458 of 2,747 inventorsTop 20%
🗺 Massachusetts: #9,595 of 88,656 inventorsTop 15%
Overall (All Time): #362,543 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12318365 Inhibition of dipeptide repeat proteins Alan Premasiri, Anna Gill 2025-06-03
12275793 Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders John M. Lincecum, Bingbing Jiang, Steven Perrin, Alan Gill, Cynthia A. Gill 2025-04-15
11857534 Inhibition of dipeptide repeat proteins Alan Premasiri, Anna Gill 2024-01-02
11692040 Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders John M. Lincecum, Bingbing Jiang, Steven Perrin, Alan Gill, Cynthia A. Gill 2023-07-04
11660324 Copper complexes for treatment of neurodegenerative disorders Steven Perrin, Alan Gill, Theo Hatzipetros, Kyle Denton, Matvey Lukashev 2023-05-30
11607402 Inhibition of dipeptide repeat proteins Alan Premasiri, Anna Gill 2023-03-21
11014990 Anti-CD40L antibodies John M. Lincecum, Bingbing Jiang, Steven Perrin, Alan Gill, Cynthia A. Gill 2021-05-25
10683356 Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies John M. Lincecum, Bingbing Jiang, Steven Perrin, Alan Gill, Cynthia A. Gill 2020-06-16
10106618 Anti-CD40L antibodies John M. Lincecum, Bingbing Jiang, Steven Perrin, Alan Gill, Cynthia A. Gill 2018-10-23
9044459 Method for the treatment of neurodegenerative diseases Steven Perrin, John M. Lincecum, Alan Gill 2015-06-02
8946301 Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis Steven Perrin, John M. Lincecum, Alan Gill 2015-02-03
8673308 Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases Steven Perrin, John M. Lincecum, Alan Gill 2014-03-18
8435514 Method for the treatment of neurodegenerative diseases Steven Perrin, John M. Lincecum, Alan Gill 2013-05-07